New York University; Private Coll/Univ - General Obligation Oct 09

  • ID: 1953314
  • October 2009
  • Region: New York
  • Standard & Poors
1 of 3

Standard & Poor's Ratings Services assigned its 'AA-' long-term rating to the New York State Dormitory Authority's series 2009A and 2009B revenue bonds, issued for New York University (NYU) and NYU's series 2009 taxable bonds. Standard & Poor's also affirmed its 'AA-' rating on NYU's parity debt. Moderate financial resources and a high debt level are offset by the university's comprehensive nature. The outlook is stable. The rating is supported by the university's: Good financial operations, characterized by positive operating performance and a diverse stream of revenues; Strong enrollment and demand profile as one of the U.S.'s largest private institutions; Successful fundraising efforts demonstrated by the $3.07 billion raised toward a $2.5 billion fundraising campaign as of Aug. 31, 2008,...

Companies mentioned in this report are:
- New York Univ
- Dorm Auth of the St of New York

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- New York Univ
- Dorm Auth of the St of New York

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.